Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Hill-RomInspire Medical SystemsHaemoneticsGlobus MedicalTandem Diabetes Care
SymbolNYSE:HRCNYSE:INSPNYSE:HAENYSE:GMEDNASDAQ:TNDM
Price Information
Current Price$112.02$217.54$116.58$67.57$87.69
52 Week RangeBuyBuyBuyBuyBuy
MarketRank™
Overall Score1.81.21.61.41.6
Analysis Score1.41.42.51.43.3
Community Score2.52.42.22.82.5
Dividend Score1.70.00.00.00.0
Ownership Score1.71.71.70.81.7
Earnings & Valuation Score1.90.61.91.90.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$121.00$168.55$144.80$66.40$115.92
% Upside from Price Target8.02% upside-22.52% downside24.21% upside-1.73% downside32.20% upside
Trade Information
Market Cap$7.43 billion$5.91 billion$5.92 billion$6.74 billion$5.48 billion
Beta0.581.710.561.020.31
Average Volume455,386236,584401,714474,770789,281
Sales & Book Value
Annual Revenue$2.88 billion$82.05 million$988.48 million$785.37 million$362.30 million
Price / Sales2.5872.035.998.5915.13
Cashflow$11.28 per shareN/A$5.16 per share$2.30 per shareN/A
Price / Cash9.93N/A22.5929.41N/A
Book Value$25.92 per share$5.81 per share$11.67 per share$14.05 per share$3.30 per share
Price / Book4.3237.449.994.8126.57
Profitability
Net Income$223 million$-33,240,000.00$76.53 million$155.21 million$-24,750,000.00
EPS$5.53($1.40)$3.31$1.68($0.22)
Trailing P/E Ratio33.74N/A56.3273.45N/A
Forward P/E Ratio18.21N/A33.2133.12N/A
P/E Growth3.00N/A5.172.89N/A
Net Margins7.74%-61.07%11.76%12.36%-11.10%
Return on Equity (ROE)22.71%-32.23%22.85%9.85%-10.98%
Return on Assets (ROA)8.01%-26.42%10.40%9.04%-5.59%
Dividend
Annual Payout$0.96N/AN/AN/AN/A
Dividend Yield0.86%N/AN/AN/AN/A
Three-Year Dividend Growth22.22%N/AN/AN/AN/A
Payout Ratio17.36%N/AN/AN/AN/A
Years of Consecutive Dividend Growth1 YearsN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.96%0.11%0.44%N/A0.61%
Current Ratio1.43%14.67%2.25%8.12%5.61%
Quick Ratio1.06%14.18%1.34%5.80%4.94%
Ownership Information
Institutional Ownership Percentage83.75%96.30%96.22%64.35%88.60%
Insider Ownership Percentage0.65%6.60%1.63%25.63%6.00%
Miscellaneous
Employees10,0003413,0042,2001,500
Shares Outstanding66.36 million27.17 million50.82 million99.80 million62.51 million
Next Earnings Date4/30/2021 (Confirmed)5/4/2021 (Confirmed)5/4/2021 (Estimated)5/6/2021 (Estimated)5/5/2021 (Confirmed)
OptionableOptionableOptionableOptionableOptionableOptionable
SourceHeadline
Tandem Diabetes Care to Announce First Quarter 2021 Financial Results on May 5, 2021Tandem Diabetes Care to Announce First Quarter 2021 Financial Results on May 5, 2021
finance.yahoo.com - April 6 at 6:09 PM
May 2022 Options Now Available For Tandem Diabetes Care (TNDM)May 2022 Options Now Available For Tandem Diabetes Care (TNDM)
nasdaq.com - April 5 at 4:43 PM
Tandem Diabetes Care (NASDAQ:TNDM) Price Target Lowered to $95.00 at SVB LeerinkTandem Diabetes Care (NASDAQ:TNDM) Price Target Lowered to $95.00 at SVB Leerink
americanbankingnews.com - April 1 at 10:18 AM
Tandem Diabetes Care (NASDAQ:TNDM) PT Lowered to $95.00 at SVB LeerinkTandem Diabetes Care (NASDAQ:TNDM) PT Lowered to $95.00 at SVB Leerink
marketbeat.com - April 1 at 8:25 AM
Tandem Diabetes Care (NASDAQ:TNDM) Stock Rating Reaffirmed by OppenheimerTandem Diabetes Care (NASDAQ:TNDM) Stock Rating Reaffirmed by Oppenheimer
americanbankingnews.com - March 31 at 8:36 AM
Tandem Diabetes Cares (TNDM) Buy Rating Reiterated at OppenheimerTandem Diabetes Care's (TNDM) Buy Rating Reiterated at Oppenheimer
marketbeat.com - March 31 at 8:00 AM
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Given Average Recommendation of "Buy" by BrokeragesTandem Diabetes Care, Inc. (NASDAQ:TNDM) Given Average Recommendation of "Buy" by Brokerages
americanbankingnews.com - March 28 at 5:00 AM
Tandem Diabetes Care, Inc. (TNDM) Down 13.2% Since Last Earnings Report: Can It Rebound?Tandem Diabetes Care, Inc. (TNDM) Down 13.2% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - March 26 at 12:39 PM
First Week of November 19th Options Trading For Tandem Diabetes Care (TNDM)First Week of November 19th Options Trading For Tandem Diabetes Care (TNDM)
nasdaq.com - March 19 at 5:36 PM
Here’s Why Tandem Diabetes Care (TNDM) Became Alger Small Cap’s Top DetractorHere’s Why Tandem Diabetes Care (TNDM) Became Alger Small Cap’s Top Detractor
feedproxy.google.com - March 15 at 12:58 PM
Tandem (TNDM) Grows on Abbott, Dexcom Pacts Amid COVID-19 WoesTandem (TNDM) Grows on Abbott, Dexcom Pacts Amid COVID-19 Woes
finance.yahoo.com - March 12 at 12:45 PM
Tandem Diabetes Care (NASDAQ:TNDM) Has Debt But No Earnings; Should You Worry?Tandem Diabetes Care (NASDAQ:TNDM) Has Debt But No Earnings; Should You Worry?
finance.yahoo.com - March 2 at 6:24 PM
Is Tandem Diabetes Care (TNDM) Stock a Buy For 2021?Is Tandem Diabetes Care (TNDM) Stock a Buy For 2021?
finance.yahoo.com - March 1 at 2:28 PM
Tandem Diabetes Care Appoints Leading Artificial Pancreas Researcher Dr. Jordan Pinsker as Medical DirectorTandem Diabetes Care Appoints Leading Artificial Pancreas Researcher Dr. Jordan Pinsker as Medical Director
finance.yahoo.com - March 1 at 9:28 AM
Tandem Diabetes Care EPS beats by $0.10, beats on revenueTandem Diabetes Care EPS beats by $0.10, beats on revenue
seekingalpha.com - February 27 at 5:48 PM
Tandem Diabetes Surpasses 4Q Estimates; Shares Rise 4%Tandem Diabetes Surpasses 4Q Estimates; Shares Rise 4%
finance.yahoo.com - February 26 at 10:25 AM
Analysts Conflicted on These Healthcare Names: Tandem Diabetes Care (TNDM), SAGE Therapeutics (SAGE) and G1 Therapeutics (GTHX)Analysts Conflicted on These Healthcare Names: Tandem Diabetes Care (TNDM), SAGE Therapeutics (SAGE) and G1 Therapeutics (GTHX)
smarteranalyst.com - February 25 at 1:34 PM
Tandem Diabetes (TNDM) Q4 Earnings, Revenues Top EstimatesTandem Diabetes' (TNDM) Q4 Earnings, Revenues Top Estimates
nasdaq.com - February 25 at 1:34 PM
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2020 Financial Results and 2021 Financial GuidanceTandem Diabetes Care Announces Fourth Quarter and Full Year 2020 Financial Results and 2021 Financial Guidance
finance.yahoo.com - February 24 at 7:34 PM
A Preview Of Tandem Diabetes Cares EarningsA Preview Of Tandem Diabetes Care's Earnings
finance.yahoo.com - February 23 at 1:53 PM
Tandem Diabetes Care, Inc. (TNDM) Reports Next Week: Wall Street Expects Earnings GrowthTandem Diabetes Care, Inc. (TNDM) Reports Next Week: Wall Street Expects Earnings Growth
nasdaq.com - February 17 at 6:58 PM
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021
finance.yahoo.com - January 19 at 6:13 PM
2 Healthcare Stocks That Crushed the Market Last Year -- And Still Have Room to Grow2 Healthcare Stocks That Crushed the Market Last Year -- And Still Have Room to Grow
finance.yahoo.com - January 12 at 8:15 AM
Tandem Diabetes Care IncTandem Diabetes Care Inc
bloomberg.com - January 2 at 12:12 AM
When Will Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Turn A Profit?When Will Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Turn A Profit?
finance.yahoo.com - December 29 at 12:51 PM
Tandem Diabetes Care Breaks Above 200-Day Moving Average - Bullish for TNDMTandem Diabetes Care Breaks Above 200-Day Moving Average - Bullish for TNDM
nasdaq.com - December 23 at 1:10 PM
Is TNDM A Good Stock To Buy According To Hedge Funds?Is TNDM A Good Stock To Buy According To Hedge Funds?
finance.yahoo.com - December 21 at 1:10 PM
DateCompanyBrokerageAction
2/16/2021Hill-RomRaymond JamesBoost Price Target
2/8/2021Hill-RomMorgan StanleyBoost Price Target
2/8/2021Hill-RomRobert W. BairdBoost Price Target
11/4/2020Hill-RomNeedham & Company LLCDowngrade
10/1/2020Hill-RomKeyCorpLower Price Target
5/4/2020Hill-RomUBS GroupLower Price Target
4/14/2020Hill-RomBarclaysReiterated Rating
3/2/2021Inspire Medical SystemsSVB LeerinkBoost Price Target
3/2/2021Inspire Medical SystemsPiper SandlerBoost Price Target
2/24/2021Inspire Medical SystemsLake Street CapitalBoost Price Target
1/4/2021Inspire Medical SystemsBank of AmericaDowngrade
12/15/2020Inspire Medical SystemsThe Goldman Sachs GroupDowngrade
11/3/2020Inspire Medical SystemsWells Fargo & CompanyBoost Price Target
11/3/2020Inspire Medical SystemsOppenheimerUpgrade
9/22/2020Inspire Medical SystemsJPMorgan Chase & Co.Initiated Coverage
8/21/2020Inspire Medical SystemsStifel NicolausBoost Price Target
2/3/2021HaemoneticsBarrington ResearchUpgrade
1/21/2021HaemoneticsJMP SecuritiesBoost Price Target
3/31/2020HaemoneticsCJS SecuritiesUpgrade
2/18/2021Globus MedicalCitigroupBoost Price Target
2/18/2021Globus MedicalBTIG ResearchBoost Price Target
1/8/2021Globus MedicalCredit Suisse GroupBoost Price Target
12/8/2020Globus MedicalSmith Barney CitigroupInitiated Coverage
12/8/2020Globus MedicalCitigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellInitiated Coverage
8/6/2020Globus MedicalCanaccord GenuityBoost Price Target
8/6/2020Globus MedicalNorthland SecuritiesUpgrade
7/31/2020Tandem Diabetes CareCraig HallumBoost Price Target
7/31/2020Tandem Diabetes CareGuggenheimUpgrade
7/7/2020Tandem Diabetes CareCowenBoost Price Target
(Data available from 4/12/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.